288 related articles for article (PubMed ID: 29599748)
41. Peculiarities of Precocious Puberty in Boys and Girls With McCune-Albright Syndrome.
Corica D; Aversa T; Pepe G; De Luca F; Wasniewska M
Front Endocrinol (Lausanne); 2018; 9():337. PubMed ID: 29988390
[TBL] [Abstract][Full Text] [Related]
42. McCune-Albright syndrome, a rare form of precocious puberty: Diagnosis, treatment, and follow-up.
Gryngarten M; Comar H; Arcari A; Boulgourdjian E; Escobar ME; Domené H
Arch Argent Pediatr; 2021 Oct; 119(5):e420-e427. PubMed ID: 34569743
[TBL] [Abstract][Full Text] [Related]
43. McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia.
Collins MT; Singer FR; Eugster E
Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S4. PubMed ID: 22640971
[TBL] [Abstract][Full Text] [Related]
44. Neonatal McCune-Albright Syndrome: A Unique Syndromic Profile With an Unfavorable Outcome.
Corsi A; Cherman N; Donaldson DL; Robey PG; Collins MT; Riminucci M
JBMR Plus; 2019 Aug; 3(8):e10134. PubMed ID: 31485549
[TBL] [Abstract][Full Text] [Related]
45. A boy with McCune-Albright syndrome associated with GH secreting pituitary microadenoma. Clinical findings and response to treatment.
Papadopoulou M; Doula S; Kitsios K; Kaltsas T; Kosta K
Hormones (Athens); 2006; 5(3):205-9. PubMed ID: 16950755
[TBL] [Abstract][Full Text] [Related]
46. Hyperthyroidism with fibrous dysplasia: an unusual presentation of McCune-Albright syndrome.
Bhat MH; Bhadada S; Dutta P; Bhansali A; Mittal BR
Exp Clin Endocrinol Diabetes; 2007 May; 115(5):331-3. PubMed ID: 17516298
[TBL] [Abstract][Full Text] [Related]
47. Otalgia revealing McCune-Albright syndrome: A case report.
Sbai AA; Es-Salhi F; Tsen AA; Fahd Elayoubi
Ann Med Surg (Lond); 2022 Oct; 82():104706. PubMed ID: 36268423
[TBL] [Abstract][Full Text] [Related]
48. The Clinical Spectrum of McCune-Albright Syndrome and Its Management.
Spencer T; Pan KS; Collins MT; Boyce AM
Horm Res Paediatr; 2019; 92(6):347-356. PubMed ID: 31865341
[TBL] [Abstract][Full Text] [Related]
49. EFFICACY AND SAFETY OF BISPHOSPHONATE THERAPY IN MCCUNE-ALBRIGHT SYNDROME-RELATED POLYOSTOTIC FIBROUS DYSPLASIA: A SINGLE-CENTER EXPERIENCE.
Wang Y; Wang O; Jiang Y; Li M; Xia W; Meng X; Xing X
Endocr Pract; 2019 Jan; 25(1):23-30. PubMed ID: 30383490
[TBL] [Abstract][Full Text] [Related]
50. Brain and eye involvement in McCune-Albright Syndrome: clinical and translational insights.
Mascioli I; Iapadre G; Ingrosso D; Donato GD; Giannini C; Salpietro V; Chiarelli F; Farello G
Front Endocrinol (Lausanne); 2023; 14():1092252. PubMed ID: 37274327
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic journey for individuals with fibrous dysplasia / McCune albright syndrome (FD/MAS).
Song K; Shrestha R; Delaney H; Vijjhalwar R; Turner A; Sanchez M; Javaid MK
Orphanet J Rare Dis; 2024 Feb; 19(1):50. PubMed ID: 38326833
[TBL] [Abstract][Full Text] [Related]
52. Expression of RANKL in breast cancer tissue in patients with fibrous dysplasia/McCune-Albright syndrome.
Meier ME; Hagelstein-Rotman M; Majoor BCJ; Geels RES; Appelman-Dijkstra NM; Bravenboer N
Bone; 2023 Apr; 169():116679. PubMed ID: 36652988
[TBL] [Abstract][Full Text] [Related]
53. Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone?
Hannon TS; Noonan K; Steinmetz R; Eugster EA; Levine MA; Pescovitz OH
J Pediatr; 2003 May; 142(5):532-8. PubMed ID: 12756386
[TBL] [Abstract][Full Text] [Related]
54. "Café-au-lait spots" caused by vitiligo in McCune-Albright syndrome.
Whyte MP; Podgornik MN; Zerega J; Reinus WR
J Bone Miner Res; 2000 Dec; 15(12):2521-3. PubMed ID: 11127218
[TBL] [Abstract][Full Text] [Related]
55. Radioiodine treatment in McCune-Albright syndrome with hyperthyroidism.
Chakraborty D; Mittal BR; Kashyap R; Manohar K; Bhattacharya A; Bhansali A
Indian J Endocrinol Metab; 2012 Jul; 16(4):654-6. PubMed ID: 22837937
[TBL] [Abstract][Full Text] [Related]
56. MR and CT findings of cyst degeneration of sphenoid bone in McCune-Albright syndrome: a case report.
Li P; Zhang ZR; Jiang Y; Xia XD; Wang D; Li XF
Cases J; 2009 Dec; 2():9376. PubMed ID: 20062549
[TBL] [Abstract][Full Text] [Related]
57. [Clinical and molecular study of Chilean patients with McCune-Albright syndrome].
Román R; Johnson MC; Codner E; Cattani A; García H; Mericq V; Boric A; Muñoz M; Schneider R; Cassorla F
Rev Med Chil; 2001 Dec; 129(12):1365-72. PubMed ID: 12080873
[TBL] [Abstract][Full Text] [Related]
58. Treatment protocols for growth hormone-secreting pituitary adenomas combined with craniofacial fibrous dysplasia: A case report of atypical McCune-Albright syndrome.
Xu J; Li X; Lv CS; Chen Y; Wang M; Liu JF; Gui L
Exp Ther Med; 2014 Sep; 8(3):877-880. PubMed ID: 25120617
[TBL] [Abstract][Full Text] [Related]
59. Analyses of variable panoramic radiographic characteristics of maxillo-mandibular fibrous dysplasia in McCune-Albright syndrome.
Akintoye SO; Otis LL; Atkinson JC; Brahim J; Kushner H; Robey PG; Collins MT
Oral Dis; 2004 Jan; 10(1):36-43. PubMed ID: 14996293
[TBL] [Abstract][Full Text] [Related]
60. Pamidronic acid and cabergoline as effective long-term therapy in a 12-year-old girl with extended facial polyostotic fibrous dysplasia, prolactinoma and acromegaly in McCune-Albright syndrome: a case report.
Classen CF; Mix M; Kyank U; Hauenstein C; Haffner D
J Med Case Rep; 2012 Jan; 6():32. PubMed ID: 22273876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
